Mortality Analysis of STEMI Patients in Belgium

This study is currently recruiting participants.

Verified by Universiteit Antwerpen, July 2008

Sponsors and Collaborators:	Universiteit Antwerpen Belgian Government
Information provided by:	Universiteit Antwerpen
ClinicalTrials.gov Identifier:	NCT00727623

Purpose

The purpose of this observational study is to assess predictors of in hospital mortality in patients with acute myocardial infarction admitted in Belgian hospitals

Condition
Acute Myocardial Infarction

MedlinePlus related topics: Heart Attack

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Prospective Observational Study to Assess Predictors of in Hospital Mortality in STEMI Patients Admitted in Belgian Hospitals

Further study details as provided by Universiteit Antwerpen:

Primary Outcome Measures:

all cause mortality [ Time Frame: in hospital ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	5000
Study Start Date:	July 2007
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Patients with acute ST elevation myocardial infarction admitted in Belgian hospitals.

Criteria

Inclusion Criteria:

clinical diagnosis of acute myocardial infarction with ST elevation or left bundle branch blok pattern on ECG.

Exclusion Criteria:

acut myocardial infarction as an acute complication of coronary intervention.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00727623

Contacts

Contact: Marc J Claeys, MD PhD	3238214706	marc.claeys@ua.ac.be
Contact: Christiaan M Vrints, MD PhD	3238214720	christiaan.vrints@ua.ac.be

Locations

Belgium, Hainaut
Centre Hospitalier de Jolimont	Recruiting
La Louviere, Hainaut, Belgium, 7100
Contact: Antoine de Meester, MD 32 64 233011 antoine.demeester@skynet.be

Sponsors and Collaborators

Universiteit Antwerpen

Belgian Government

Investigators

Principal Investigator:

Marc J Claeys, MD.PhD

University Hospital, Antwerp

More Information

Responsible Party:	Universiteit Antwerpen ( Prof Dr M Claeys )
Study ID Numbers:	BIWAC-01
Study First Received:	July 29, 2008
Last Updated:	July 30, 2008
ClinicalTrials.gov Identifier:	NCT00727623
Health Authority:	Belgium: Ministry of Social Affairs, Public Health and the Environment

Keywords provided by Universiteit Antwerpen:

acute coronary syndrome
myocardial infarction
predictors of mortality
reperfusion therapy

Study placed in the following topic categories:

Necrosis
Heart Diseases
Myocardial Ischemia
Acute Coronary Syndrome

Vascular Diseases
Ischemia
Infarction
Myocardial Infarction

Additional relevant MeSH terms:

Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009